HPV6b virus like particles are potent immunogens without adjuvant in man

被引：130

作者：

Zhang, LF

Zhou, J

Chen, S

Cai, LL

Bao, QY

Zheng, FY

Lu, JQ

Padmanabha, J

Hengst, K

Malcolm, K

Frazer, IH ^{[1
]}

机构：

[1] Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia

[2] Wenzhou Med Coll, Dept Microbiol, Wenzhou 325003, Zhejiang, Peoples R China

[3] Wenzhou Med Coll, Dept Obstet Gynaecol, Wenzhou 325003, Zhejiang, Peoples R China

来源：

VACCINE | 2000年 / 18卷 / 11-12期

基金：

英国医学研究理事会;

关键词：

papillomavirus; vaccines; virus like particles;

D O I：

10.1016/S0264-410X(99)00351-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Subjects with genital warts were immunized three times or more with HPV6b VLPs without adjuvant. All immunized subjects had DTH to HPV6b L1 protein. Of 32 subjects, nine had HPV6b specific antibody prior to immunization and 22 acquired antibody with immunization. VLP specific antibody increased following a single immunization in 6 of 8 subjects with low level antibody at recruitment. Complete regression of genital warts was observed in 25 of 33 evaluable subjects over the 20-week observation period. We conclude that immunization with HPV6b L1 VLPs without adjuvant induces immunity to the L1 protein epitopes recognised during natural infection, and may accelerate regression of warts. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

页码：1051 / 1058

页数：8

共 44 条

[11]

CHRISTOPHERSEN J, 1993, ACTA DERM-VENEREOL, V73, P223

[12] L1-specific protection from tumor challenge elicited by HPV16 virus-like particles [J].

De Bruijn, MLH ;

Greenstone, HL ;

Vermeulen, H ;

Melief, CJM ;

Lowy, DR ;

Schiller, JT ;

Kast, WM .

VIROLOGY, 1998, 250 (02) :371-376

[13] Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles [J].

Dupuy, C ;

BuzoniGatel, D ;

Touze, A ;

LeCann, P ;

Bout, D ;

Coursaget, P .

MICROBIAL PATHOGENESIS, 1997, 22 (04) :219-225

[14] Self-administered topical 5% imiquimod cream for external anogenital warts [J].

Edwards, L ;

Ferenczy, A ;

Eron, L ;

Baker, D ;

Owens, ML ;

Fox, TL ;

Hougham, AJ ;

Schmitt, KA .

ARCHIVES OF DERMATOLOGY, 1998, 134 (01) :25-30

[15] INTERFERON THERAPY FOR CONDYLOMATA ACUMINATA [J].

ERON, LJ ;

JUDSON, F ;

TUCKER, S ;

PRAWER, S ;

MILLS, J ;

MURPHY, K ;

HICKEY, M ;

ROGERS, M ;

FLANNIGAN, S ;

HIEN, N ;

KATZ, HI ;

GOLDMAN, S ;

GOTTLIEB, A ;

ADAMS, K ;

BURTON, P ;

TANNER, D ;

TAYLOR, E ;

PEETS, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (17) :1059-1064

[16] Identification of the alpha(6) integrin as a candidate receptor for papillomaviruses [J].

Evander, M ;

Frazer, IH ;

Payne, E ;

Qi, YM ;

Hengst, K ;

McMillan, NAJ .

JOURNAL OF VIROLOGY, 1997, 71 (03) :2449-2456

[17] Immunology of papillomavirus infection [J].

Frazer, IH .

CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :484-491

[18]

FRAZER IH, 1997, CLIN APPL INTERFERON, P79

[19] NATURAL INTERFERON ALFA FOR TREATMENT OF CONDYLOMATA ACUMINATA [J].

FRIEDMANKIEN, AE ;

ERON, LJ ;

CONANT, M ;

GROWDON, W ;

BADIAK, H ;

BRADSTREET, PW ;

FEDORCZYK, D ;

TROUT, JR ;

PLASSE, TF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (04) :533-538

[20]

Gentile G., 1994, Clinical and Experimental Obstetrics and Gynecology, V21, P198

← 1 2 3 4 5 →